Sign in
4

Changes in Ownership

TherapeuticsMD, Inc. Filed Acc 0001209191-22-046969

Director acquired 1,984 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Collins Cooper C. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-08-18 Exercise or conversion : show line 1 in the form +1,984 46,722 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-08-18 Exercise or conversion : show line 2 in the form Restricted Stock Units −1,984 0 D
Loading xslF345X03/doc4.xml…